OmanDocSign in

Curriculum · Metabolic and Endocrine and Diabetes Mellitus

Cystic fibrosis-related diabetes

What it is

CF-related diabetes, written CFRD, is the endocrine half of pancreatic involvement in cystic fibrosis. Under organ involvement the pancreas carries two words, exocrine and endocrine, and the endocrine one is CFRD.

It appears twice more in the same set. Among the complications it is listed as one of the CF-related diseases together with liver disease, written CFLD. And among the manifestations it is listed under endocrine and other, together with infertility in males. In the list of how the child presents, diabetes mellitus stands first, ahead of recurrent infections with cough, purulent sputum and SOB; the gastrointestinal symptoms of steatorrhoea, failure to thrive in childhood, rectal prolapse, meconium ileus or distal intestinal obstruction; heat stroke and salt depletion; and sterility in men, with no vas deferens and epididymis, with decreased fertility in women. The genetic basis is autosomal recessive on chromosome 7, affecting the protein for cAMP-regulated chloride channels, and the commonest gene is F508.

Causes and risk

The table of CFTR mutation classes is presented as the type of mutations in the CFTR gene including those that increase the risk for diabetes development, so the mutation is where the risk is set.

The six classes are: class I, no CFTR synthesis, prevalence 10%; class II, CFTR trafficking defect, 88%; class III, defective channel regulation, 4%; class IV, decreased channel conductance; class V, reduced CFTR synthesis; and class VI, decreased CFTR stability. Increased risk for CFRD is written over the first three of these classes - class I, class II and class III - while classes IV, V and VI fall outside it, and the class-specific therapy runs alongside each: read-through compounds for class I, correctors for class II, and potentiators for classes III and IV. Chronic pancreatitis makes the same link from the other side. Its causes are alcohol, the most common, and cystic fibrosis; exocrine pancreatic insufficiency gives steatorrhea and endocrine pancreatic insufficiency gives diabetes, with an increase in serum glucose and HbA1c on investigation. Young adults with chronic pancreatitis require CF testing.

How it is diagnosed

Cystic fibrosis itself is confirmed by the sweat chloride test, where a concentration over 60 mmol/l is indicative of cystic fibrosis; read in mEq/L the bands are positive above 60, intermediate 30-60, and negative under 30. The lower band is not set the same way everywhere: it is reported as negative under 30 mEq/L in one source, and as a normal value under 40 mEq/l in another, where 30-59 mmol/L is called borderline or equivocal sweat chloride and CFTR mutation analysis helps clarify the diagnosis.

A false positive result of the sweat test has its own named causes: malnutrition; nephrogenic diabetes insipidus; hypothyroidism and hypoparathyroidism; and most commonly skin oedema with dehydration.

The diagnostic criteria pair a phenotype with a test. One or more characteristic phenotypic features consistent with CF, that is chronic sinopulmonary disease, gastrointestinal and nutritional abnormalities, salt loss syndromes, or male urogenital abnormalities resulting in obstructive azoospermia; or a history of CF in a sibling; or a positive newborn screening test result; and with that, an increased sweat chloride concentration, or identification of two disease causing CF mutations, or demonstration of abnormal nasal epithelial ion transport. Named beside these are urine sugar, faecal fat and the genetic test; the chest x ray may show the bleb sign, small subpleural thin walled air containing spaces 1-2 cm in diameter; and the pulmonary function tests show a mixed obstructive and restrictive pattern. The diabetes is diagnosed on the WHO criteria. In a symptomatic patient, a fasting glucose greater than or equal to 7.0 mmol/l, or a random glucose greater than or equal to 11.1 mmol/l, including after a 75g oral glucose tolerance test. In an asymptomatic patient the same criteria apply but must be demonstrated on two separate occasions. An HbA1c greater than or equal to 6.5%, that is 48 mmol/mol, is diagnostic of diabetes mellitus, while an HbA1c below 6.5% does not exclude diabetes, since it is not as sensitive as fasting samples; in a patient without symptoms the test must be repeated to confirm the diagnosis, and misleading HbA1c results can be caused by increased red cell turnover.